InvestSMART

EBR Systems Inc (ASX: EBR) - Announcements

Current share price for EBR : $0.125 0.005 (4.17%)+

ASX company news and announcements for EBR Systems Inc (EBR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EBR Systems Inc (EBR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EBR Systems Inc (EBR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EBR Systems Inc (EBR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$106 EBR schedules Day-100 Meeting with the FDA 6 Dec 2024 8:23AM $0.888 $0.125 fallen by 85.92%
$106 Change of Director's Interest Notice 27 Nov 2024 9:07AM $0.935 $0.125 fallen by 86.63%
$106 Application for quotation of securities - EBR 27 Nov 2024 9:05AM $0.935 $0.125 fallen by 86.63%
$106 Q3 2024 Quarterly Activity Report and Form 10-Q submission 13 Nov 2024 9:13AM $1.015 $0.125 fallen by 87.68%
$106 Notification of cessation of securities - EBR 7 Nov 2024 8:58AM $0.988 $0.125 fallen by 87.34%
$106 Notification regarding unquoted securities - EBR 6 Nov 2024 10:14AM $1.000 $0.125 fallen by 87.50%
$106 Form S-8 Registration Statement 29 Oct 2024 1:44PM $1.020 $0.125 fallen by 87.75%
$106 Notice of Date for Q3 2024 Quarterly Report and Form 10-Q 25 Oct 2024 8:42AM $1.055 $0.125 fallen by 88.15%
$106 Substantial Holding Notification 22 Oct 2024 10:03AM $1.040 $0.125 fallen by 87.98%
$106 Appendix 3Y 17 Oct 2024 8:20AM $1.065 $0.125 fallen by 88.26%
$106 EBR submits NTAP Application 16 Oct 2024 10:41AM $1.075 $0.125 fallen by 88.37%
$106 Application for quotation of securities - EBR 16 Oct 2024 10:02AM $1.050 $0.125 fallen by 88.10%
$106 EBR SEC Form 3 inital director beneficial ownership filings 15 Oct 2024 11:25AM $1.100 $0.125 fallen by 88.64%
$106 Completion of Retail Entitlement Offer 14 Oct 2024 8:57AM $1.070 $0.125 fallen by 88.32%
$106 Granting of ASX waiver U.S. Financial Reporting Requirements 2 Oct 2024 9:55AM $0.910 $0.125 fallen by 86.26%
$106 FDA commences substantive review of EBR PMA application 30 Sep 2024 8:32AM $0.880 $0.125 fallen by 85.80%
$106 Cleansing Notice 26 Sep 2024 8:55AM $0.840 $0.125 fallen by 85.12%
$106 Application for quotation of securities - EBR 25 Sep 2024 10:12AM $0.860 $0.125 fallen by 85.47%
$106 Notification to Ineligible Securityholder Letter 24 Sep 2024 10:28AM $0.868 $0.125 fallen by 85.59%
$106 Notification to Eligible Securityholder Letter 24 Sep 2024 10:25AM $0.868 $0.125 fallen by 85.59%
$106 Retail Entitlement Offer Booklet 24 Sep 2024 10:24AM $0.868 $0.125 fallen by 85.59%
$106 EBR Placement and Institutional Entitlement Offer Completed 20 Sep 2024 9:10AM $0.975 $0.125 fallen by 87.18%
$106 Amendment to Form 10 19 Sep 2024 8:37AM $0.975 $0.125 fallen by 87.18%
$106 Proposed issue of securities - EBR 18 Sep 2024 9:35AM $0.975 $0.125 fallen by 87.18%
$106 Capital Raising Investor Presentation 18 Sep 2024 9:35AM $0.975 $0.125 fallen by 87.18%

201 - 225 of 513 results

Page 9 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.